Connect Biopharma Holdings's market cap is currently ―. The company's EPS TTM is $-1.585; its P/E ratio is -0.85; Connect Biopharma Holdings is scheduled to report earnings on September 10, 2024, and the estimated EPS forecast is $-0.27. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Jun 22	Dec 21	Jun 21
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	-	-	-	-	-
EBITDA	-	-	-	-	-
Net Income Common Stockholders	-	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	¥ 118.65M	¥ 550.27M	¥ 1.28B	¥ 1.71B	¥ 2.03B
Total Assets	¥ 125.89M	¥ 174.01M	¥ 1.58B	¥ 1.86B	¥ 2.17B
Total Debt	¥ 465.00K	¥ 3.00M	¥ 3.77M	¥ 793.00K	¥ 1.10M
Net Debt	¥ -118.19M	¥ -547.28M	¥ -1.28B	¥ -1.71B	¥ -2.02B
Total Liabilities	¥ 24.85M	¥ 16.52M	¥ 145.65M	¥ 119.83M	¥ 91.11M
Stockholders Equity	¥ 101.04M	¥ 131.84M	¥ 1.43B	¥ 1.74B	¥ 2.08B
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in CNY

Connect Biopharma Holdings Earnings and Revenue History

Income Statement >

Connect Biopharma Holdings Debt to Assets

Balance Sheet >

Connect Biopharma Holdings Cash Flow

Cash Flow >

Connect Biopharma Holdings Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing